Ausgabe 1/2023
Inhalt (21 Artikel)
Head-to-head comparison of contrast-enhanced mammography and contrast-enhanced MRI for assessing pathological complete response to neoadjuvant therapy in patients with breast cancer: a meta-analysis
Min Kaiyin, Tong Lingling, Tang Leilei, Li Wenjia, Ji Bin
Breast cancer and incidence of type 2 diabetes mellitus: a systematic review and meta-analysis
Nanna Jordt, Kasper Aalbæk Kjærgaard, Reimar W. Thomsen, Signe Borgquist, Deirdre Cronin-Fenton
Clinical outcome and therapeutic impact on neuroendocrine neoplasms of the breast: a national cancer database study
Libo Yang, Heather Lin, Yu Shen, Madhuchhanda Roy, Constance Albarracin, Qingqing Ding, Lei Huo, Hui Chen, Bing Wei, Hong Bu, Isabelle Bedrosian, Yun Wu
Numerical and physical modeling of breast cancer based on image fusion and artificial intelligence
Bartosz Dołęga-Kozierowski, Piotr Kasprzak, Michał Lis, Bartłomiej Szynglarewicz, Rafał Matkowski, Marek Sawicki, Mateusz Dymek, Adrianna Szumiejko, Gustavo Carmo, Artur Kwiatkowski, Daniel Grzegorz Soliński, Mariusz Ptak
Ultrasound and clinicopathological characteristics-based model for prediction of pathologic response to neoadjuvant chemotherapy in HER2-positive breast cancer: a case–control study
Lin Sui, Yuqi Yan, Tian Jiang, Di Ou, Chen Chen, Min Lai, Chen Ni, Xi Zhu, Liping Wang, Chen Yang, Wei Li, Jincao Yao, Dong Xu
Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial
Cristiano de Pádua Souza, Ana Suellen Barroso Carneiro, Ana Cecília de Oliveira Lessa, Domício Carvalho Lacerda, Carlos Eduardo Paiva, Marina Moreira Costa Zorzetto, Ana Julia Aguiar de Freitas, Iara Viana Vidigal Santana, Marco Antonio de Oliveira, Edenir Inêz Palmero, Márcia Maria Chiquitelli Marques, Tomás Reinert
Association between 21-gene-assay and detection of disseminated tumor cells in patients with early breast cancer: results from the IRMA trial
Léa L. Volmer, Dominik Dannehl, Tobias Engler, Markus Hahn, Christina B. Walter, Markus Wallwiener, Sara Y. Brucker, Florin-Andrei Taran, Andreas D. Hartkopf
Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer
Matthew G. Davey, Ray Abbas, Eoin P. Kerin, Maire Caitlin Casey, Andrew McGuire, Ronan M. Waldron, Helen M. Heneghan, John Newell, Ailbhe M. McDermott, Maccon M. Keane, Aoife J. Lowery, Nicola Miller, Michael J. Kerin
CDK4/6 inhibitors versus weekly paclitaxel for treatment of ER+/HER2- advanced breast cancer with impending or established visceral crisis
Roya Behrouzi, Anne C. Armstrong, Sacha J. Howell
High neuroticism is associated with common late adverse effects in a nationwide sample of long-term breast cancer survivors
Alv A. Dahl, Solveig K. Smedsland, Kathrine F. Vandraas, Synne K. Bøhn, Ragnhild S. Falk, Cecilie E. Kiserud, Kristin V. Reinertsen
COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019–2021
Judith A. Malmgren, Boya Guo, Mary K. Atwood, Paula Hallam, Laura A. Roberts, Henry G. Kaplan
Increases in BMI contribute to worsening inflammatory biomarkers related to breast cancer risk in women: a longitudinal study
Yu Hao, Jinyu Xiao, Ping Fu, Lanping Yan, Xunying Zhao, Xueyao Wu, Min Zhou, Xiaofan Zhang, Bin Xu, Xingyue Li, Zhenmi Liu, Chunxia Yang, Xin Wang, Lu Long, Xia Jiang, Jiaqiang Liao, Ben Zhang, Jiayuan Li
The impact of nurse navigation on timeliness to treatment for benign high-risk breast pathology
Catherine S. Barker, Catherine W. Chung, Rupak Mukherjee, Julie B. Siegel, David J. Cole, Mark A. Lockett, Nancy Klauber-DeMore, Andrea M. Abbott
Effect of neighborhood deprivation index on breast cancer survival in the United States
Arya Mariam Roy, Anthony George, Kristopher Attwood, Sabah Alaklabi, Archit Patel, Angela R. Omilian, Song Yao, Shipra Gandhi
Factors associated with insomnia symptoms over three years among premenopausal women with breast cancer
Chloe M. Beverly Hery, Sarah A. Janse, Kimberly J. Van Zee, Elizabeth Z. Naftalis, Electra D. Paskett, Michelle J. Naughton
Changes in the incidence of early-onset breast cancer in Germany between 2010 and 2022
Niklas Gremke, Uwe Wagner, Matthias Kalder, Karel Kostev
Combining the tumor-stroma ratio with tumor-infiltrating lymphocytes improves the prediction of pathological complete response in breast cancer patients
Fengling Li, Hong Chen, Xunxi Lu, Yani Wei, Yuanyuan Zhao, Jing Fu, Xiuli Xiao, Hong Bu
Ipsilateral tumor recurrence risk in women with ductal carcinoma in situ: application of the Van Nuys Prognostic Index and the Memorial Sloan Kettering Cancer Center nomogram
Kimberlee A. Hashiba, Manisha Bahl
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes
Lauren Lenz, Chris Neff, Cara Solimeno, Elizabeth S. Cogan, Vandana G. Abramson, Judy C. Boughey, Carla Falkson, Matthew P. Goetz, James M. Ford, William J. Gradishar, Rachel C. Jankowitz, Virginia G. Kaklamani, P. Kelly Marcom, Andrea L. Richardson, Anna Maria Storniolo, Nadine M. Tung, Shaveta Vinayak, Darren R. Hodgson, Zhongwu Lai, Simon Dearden, Bryan T. Hennessy, Erica L. Mayer, Gordon B. Mills, Thomas P. Slavin, Alexander Gutin, Roisin M. Connolly, Melinda L. Telli, Vered Stearns, Jerry S. Lanchbury, Kirsten M. Timms
Effects of neighborhood disadvantage on cortisol and interviewer-rated anxiety symptoms in breast cancer patients initiating treatment
Neha Goel, Alexandra E Hernandez, Molly Ream, Estefany Saez Clarke, Bonnie B. Blomberg, Steve Cole, Michael H. Antoni
Retraction Note: Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways
C. Buchanan, I. Stigliano, H. M. Garay-Malpartida, L. Rodrigues Gomes, L. Puricelli, M. C. Sogayar, E. Bal de Kier Joffe, M. G. Peters